Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Schrodinger Inc (NQ: SDGR )

61.24 +2.22 (+3.76%)
Streaming Delayed Price Updated: 4:00 PM EDT, May 14, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press releases about Schrodinger Inc

Schrödinger Reports First Quarter 2021 Financial Results and Provides Company Update
Schrödinger reported financial results for the first quarter of 2021 and provided a company update. 
From Business Wire News Releases
Schrödinger to Present at the Bank of America Securities 2021 Virtual Healthcare Conference
Schrödinger today announced that it will participate in the Bank of America Securities 2021 Virtual Healthcare Conference. 
From Business Wire News Releases
Qiming's Portfolio Company Fanli.com Goes Public on Shanghai Stock Exchange
Qiming's portfolio company Fanli.com went public today on Shanghai Stock Exchange via a reverse merger with Jiangxi Changjiu Biochemical (SHSE: 600228). The stock price is CNY 12.25 per share at the... 
From PR Newswire
Schrödinger to Host Conference Call to Discuss First Quarter 2021 Financial Results
Schrödinger today announced that it will report first quarter 2021 financial results on May 11, 2021. 
From Business Wire News Releases
Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
Schrödinger announced grants made to newly-hired employees pursuant to the company’s 2021 Inducement Equity Incentive Plan. 
From Business Wire News Releases
Qiming's Duane Kuang, Nisa Leung Named on 2021 Forbes Midas List
Forbes today released the 2021 Midas List, a ranking of the world's top 100 venture capitalists. Duane Kuang and Nisa Leung, Managing Partners of Qiming Venture Partners, ranked on the list. 
From PR Newswire
Schrödinger Reports Preclinical Data on Novel, Selective CDC7 Inhibitors Presented at American Association for Cancer Research Annual Meeting
Schrödinger presented new preclinical data from its CDC7 inhibitor program during AACR 21 Annual Virtual Meeting. 
From Business Wire News Releases
Schrödinger to Participate in BMO BioPharma Spotlight Series: Technology-Enabled Drug Discovery
Schrödinger today announced that the company will participate in the BMO BioPharma Spotlight Series: Technology-Enabled Drug Discovery. 
From Business Wire News Releases
Schrödinger to Host Webcast in Conjunction with Presentation of Preclinical Data for Its CDC7 Program at Virtual AACR Annual Meeting
Schrödinger will host a webcast to review the preclinical data being presented at the AACR Annual Meeting. 
From Business Wire News Releases
Qiming's Portfolio Company Zhihu Lists on New York Stock Exchange
Qiming Venture Partners' portfolio company Zhihu (NYSE: ZH) on March 26th EST listed on the New York Stock Exchange. The issue price is US$9.5/ADS. The stock closed at US$8.5/ADS on the first trading... 
From PR Newswire
Qiming's Portfolio Company Connect Biopharma Lists on Nasdaq
Qiming Venture Partners' portfolio company Connect Biopharma today listed on the Nasdaq with the stock code "CNTB". The issue price is US$ 17.00/ADS. The stock opened at US$19.55/ADS and closed at... 
From PR Newswire
Schrödinger to Participate in Credit Suisse 2021 Healthcare Innovators Series: The Intersection of Drug Discovery, Drug Development and Artificial Intelligence
Schrödinger will participate in the virtual Credit Suisse 2021 Healthcare Innovators Series on March 23, 2021. 
From Business Wire News Releases
Schrödinger Announces Preclinical Data for CDC7 Program to Be Presented at AACR Virtual Annual Meeting 2021
Schrödinger announced that preclinical data from its CDC7 program will be presented at the AACR Annual Meeting. 
From Business Wire News Releases
Schrödinger Reports Financial Results for the Fourth Quarter and Full Year 2020 and Provides Outlook for 2021
Schrödinger today reported financial results for the fourth quarter and full year 2020. 
From Business Wire News Releases
Schrödinger to Present at the H.C. Wainwright Global Life Sciences Conference
Schrödinger today announced that management will provide a corporate overview during the H.C. Wainwright Global Life Sciences Conference. 
From Business Wire News Releases
Schrödinger Expands Agreement with Google Cloud to Further Bolster Its Drug Discovery and Materials Science Initiatives
Schrödinger today announced it has expanded its collaboration with Google Cloud. 
From Business Wire News Releases
Schrödinger to Present at the SVB Leerink Partners 10th Annual Global Healthcare Conference
Schrödinger today announced that management will provide a corporate overview at the SVB Leerink Partners 10th Annual Global Healthcare Conference. 
From Business Wire News Releases
Schrödinger to Host Conference Call to Discuss Fourth Quarter and Year-End 2020 Financial Results
Today Schrödinger announced that it will host a conference call and webcast on Thursday, March 4, 2021, at 8:30 a.m. ET. 
From Business Wire News Releases
First Cancer Early Screening Company Listed on HKEX as New Horizon Health Debuts
Qiming's portfolio company New Horizon Health (SEHK:6606) officially listed on the Main Board of Hong Kong Stock Exchange (HKEx) today. This is the first listed Chinese cancer early screening company. 
From PR Newswire
Qiming Venture Partners Closes RMB Fund VI at RMB 2.852 billion
Qiming Venture Partners ("Qiming") today announced the final close of our RMB Fund VI at RMB 2.852 billion. 
From PR Newswire
Qiming Venture Partners' Portfolio Company APT Medical Listed on STAR Board of Shanghai Stock Exchange
Qiming Venture Partners' portfolio company APT Medical (SHSE: 688617) today successfully listed on the Science and Technology Innovation Board (the STAR Board) of Shanghai Stock Exchange. The issue... 
From PR Newswire
Schrödinger Presents Data from Its MALT1 Inhibitor Program at the American Society of Hematology (ASH) 2020 Annual Meeting
Schrödinger, Inc. (Nasdaq: SDGR), whose physics-based software platform is transforming the way therapeutics and materials are discovered, presented preclinical data from its wholly-owned MALT1... 
From Business Wire News Releases
Schrödinger Announces a Multi-Target Drug Discovery, Development, and Commercialization Collaboration with Bristol Myers Squibb
Schrödinger, Inc. (Nasdaq: SDGR), whose physics-based software platform is transforming the way therapeutics and materials are discovered, today announced a discovery collaboration with Bristol Myers... 
From Business Wire News Releases
Qiming's Portfolio Company Antengene Lists on Main Board of HKEX
Qiming's portfolio company Antengene (SEHK: 6996) officially listed on the Main Board of The Stock Exchange of Hong Kong Limited today. The issue price is HK$18.08 per share; the stock opens at HK$... 
From PR Newswire
Qiming Venture Partners Announces Final Closing of US$ 1.2 Billion Fund VII
Fund targets early stage healthcare and technology investments 
From PR Newswire
Schrödinger, Inc. Reports Third Quarter 2020 Financial Results and Business Update
Schrödinger, Inc. (Nasdaq: SDGR), whose physics-based software platform is transforming the way therapeutics and materials are discovered, today announced financial results for the third quarter ended... 
From Business Wire News Releases
Schrödinger to Present at Upcoming Investor Conferences
Schrödinger, Inc. (Nasdaq: SDGR), whose physics-based software platform is transforming the way therapeutics and materials are discovered, today announced that members of the management team will... 
From Business Wire News Releases
Schrödinger to Host Third Quarter 2020 Financial Results Conference Call and Webcast
Schrödinger (Nasdaq: SDGR), whose physics-based software platform is transforming the way therapeutics and materials are discovered, today announced it will host a conference call and webcast on... 
From Business Wire News Releases
Schrödinger to Present Data from Its MALT1 Inhibitor Program at the American Society of Hematology (ASH) 2020 Annual Meeting
Schrödinger, Inc. (Nasdaq: SDGR), whose physics-based software platform is transforming the way therapeutics and materials are discovered, today announced it will present data from its preclinical... 
From Business Wire News Releases
Qiming's Portfolio Company Zai Lab Lists on Main Board of HKEX
Qiming's portfolio company Zai Lab (SEHK:9688, NASDAQ:ZLAB), an innovative commercial-stage biopharmaceutical company, officially listed on the Main Board of The Stock Exchange of Hong Kong Limited... 
From PR Newswire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.